PHD, Sr Scientific & Clinical Affairs, Novosanis
Biography
Jhana Hendrickx holds a Master degree in bioscience and cell gene Biotechnology, and a PhD in Biomedical sciences. Jhana joined Novosanis, a medical device company in Antwerp, Belgium in 2021. Shes in charge of scientific affairs, managing the Key Opinion Leader Network, running Scientific Advisory Boards and engaging with our customers. Also, shes in charge of clinical affairs and runs the in-house clinical trials in infectious diseases and oncology and supports trials executed by lead Principal Investigators globally.
Clinical Dx Showcase:
Novosanis
Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.
Urine as a non-invasive liquid biopsy for oncology applications
A high number of potentially informative cancer biomarkers have been found in urine.
Session Abstract – PMWC 2022 Silicon Valley
Track 6 - June 28 9.00 A.M.-4.45 P.M.,Track 6 - June 29 3.30 P.M.-3.45 P.M.,Track 6 - June 30 9.00 A.M.-1.15 P.M.
The PMWC 2022 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative
